Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRTX | BMRN | SRPT | ||
| Company | Karuna Therapeutics Inc | Biomarin Pharmaceuticals | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 329.75 | 66.32 | 132.40 | ||
| High | 329.99 | 67.30 | 133.00 | ||
| Low | 329.75 | 65.75 | 117.52 | ||
| Last | 329.83 | 66.94 | 120.42 | ||
| Change | +0.09 | +0.79 | -7.55 | ||
| % Change | +0.03% | +1.19% | -5.90% | ||
| Volume | 1,868,500 | 1,350,600 | 2,393,500 | ||
| 20-Day Average Volume | 585,565 | 1,497,410 | 860,975 | ||
| Previous Close | 329.74 | 66.15 | 127.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 319.40 | 68.80 | 126.63 | ||
| 20-Day Raw Stochastic | 99.53% | 28.24% | 18.31% | ||
| 20-Day Relative Strength | 74.08% | 35.53% | 41.29% | ||
| Weighted Alpha | +52.60 | -26.89 | +18.41 | ||
| Today's Opinion | 100% Buy | 100% Sell | 64% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.09% since 03/08/24 | +1.59% since 10/31/24 | -4.43% since 10/31/24 | ||
| Low | 318.52 on 03/11/24 | 65.45 on 11/05/24 | 117.52 on 11/07/24 | ||
| High | 329.99 on 03/15/24 | 67.64 on 11/06/24 | 133.00 on 11/07/24 | ||
| 1-Month | |||||
| %Chg | +3.27% since 02/15/24 | -2.93% since 10/07/24 | +2.23% since 10/07/24 | ||
| Low | 296.06 on 02/26/24 | 65.35 on 10/31/24 | 116.17 on 10/09/24 | ||
| High | 329.99 on 03/15/24 | 70.98 on 10/25/24 | 133.36 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | +50.08% since 12/15/23 | -22.43% since 08/07/24 | -14.02% since 08/07/24 | ||
| Low | 210.14 on 12/20/23 | 65.35 on 10/31/24 | 116.17 on 10/09/24 | ||
| High | 329.99 on 03/15/24 | 94.85 on 08/20/24 | 144.22 on 08/22/24 | ||
| 6-Month | |||||
| %Chg | +82.33% since 09/15/23 | -18.94% since 05/07/24 | -11.48% since 05/07/24 | ||
| Low | 158.38 on 10/03/23 | 65.35 on 10/31/24 | 109.91 on 05/28/24 | ||
| High | 329.99 on 03/15/24 | 94.85 on 08/20/24 | 173.25 on 06/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,582,351 | 12,607,065 | 12,203,986 | ||
| Shares Outstanding, K | 38,148 | 190,583 | 95,366 | ||
| Annual Sales | 650,000 | 2,419,230,000 | 1,243,340,000 | ||
| Annual Net Income | -433,680,000 | 167,650,000 | -535,980,000 | ||
| Last Quarter Sales | 0 | 745,740,000 | 362,930,000 | ||
| Last Quarter Net Income | -113,820,000 | 106,080,000 | 6,460,000 | ||
| 60-Month Beta | 1.18 | 0.31 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.01 on 02/22/24 | 0.91 on 10/29/24 | 0.62 on 11/06/24 | ||
| Latest Earnings Date | 05/02/24 | 10/29/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.22 | 271.76 | ||